or
Sign in to turn on 1-Click ordering.
or
Amazon Prime Free Trial required. Sign up when you check out. Learn More
Sell Back Your Copy
For a $0.57 Gift Card
Trade in
More Buying Choices
Have one to sell? Sell yours here
Management of Benign Prostatic Hypertrophy (Current Clinical Urology)
 
 
Tell the Publisher!
I'd like to read this book on Kindle

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Management of Benign Prostatic Hypertrophy (Current Clinical Urology) [Hardcover]

Kevin T. McVary (Editor)

Price: $99.50 & this item ships for FREE with Super Saver Shipping. Details
  Special Offers Available
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.
Only 1 left in stock--order soon (more on the way).
Want it delivered Tuesday, January 31? Choose One-Day Shipping at checkout. Details
Textbook Student FREE Two-Day Shipping for Students. Learn more

Formats

Amazon Price New from Used from
Hardcover $99.50  

Book Description

1588291553 978-1588291554 November 25, 2003 1
A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking sound guidance on the best approach to his patients.

Special Offers and Product Promotions

  • Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)

Editorial Reviews

From The New England Journal of Medicine

This book -- whose authors include 10 Chicago urologists, 12 other U.S. urologists, and an eminent urologist from Ireland -- reviews the anatomy, pathophysiology, and causes of benign prostatic hypertrophy, or hyperplasia (BPH), and discusses the assessment and treatment of the condition. However, an opportunity is missed in this book. One author states that "one of the most basic, yet most important, difficulties in the evaluation and management of men with BPH concerns definitions. In a strict sense, BPH is a histologic diagnosis." Both the International Consultations of the World Health Organization and the International Continence Society have recommended that the term BPH be used for histologic diagnosis, the term benign prostatic enlargement when the gland is anatomically enlarged, and the term benign prostatic obstruction when the gland produces an obstruction that is characterized by a low maximal flow rate and high voiding pressure. These distinctions are important because the loose use of the term BPH means that the characteristics of the disorder in any given patient cannot be deduced. Precise definition is needed -- for example, in describing a patient with troublesome lower urinary tract symptoms without evidence of benign prostatic enlargement or obstruction. In such a case, as is pointed out in the chapter on definitions, "urinary symptoms . . . may result from a variety of other causes." The book acknowledges the benign nature of lower urinary tract symptoms in most patients, but there is an important section on the relatively rare cases of renal impairment secondary to benign prostatic obstruction. Basic clinical assessment is covered briefly in the section on alpha-adrenergic-blocking agents, although the book stresses the usefulness of the frequency-volume chart. The section on the role of urodynamics describes the tests well and, in a well-reasoned manner, outlines the areas of dispute concerning their place in routine assessment. The sections on drug therapy cover alpha-adrenergic agonists and 5-alpha-reductase inhibitors but only briefly mention combination therapy with an agent from each group. The authors state that although it is difficult to compare various alpha-adrenergic blockers, the use of such agents can now be regarded as first-line management in primary care. The historical aspects of the 5-alpha-reductase inhibitors and the rationale behind the drugs' use are interesting. However, there is no clear statement regarding the respective roles of alpha-adrenergic blockers and 5-alpha-reductase inhibitors in treating patients with lower urinary tract symptoms, and there is little discussion of the choice between these two classes of drugs for the prevention of episodes of urinary retention and operations for prostatic obstruction. It would be helpful to see data regarding which criteria are appropriate for treatment in order to prevent a complication. However, it is not clear from many published papers whether the episodes of urinary retention that were discussed required catheterization and subsequent transurethral resection of the prostate. In keeping with the wide range of procedures that are available in the United States, chapters in the book deal with the various types of minimally invasive, and generally less effective, treatments of prostatic obstruction, including transurethral needle ablation, transurethral microwave thermotherapy, interstitial laser coagulation, high-intensity focused ultrasonography, water-induced thermotherapy, and ethanol injections. It is interesting that the book cites few data to support the use of such procedures in patients with prostatic obstruction that leads to acute retention -- the acid test for any treatment. Only transurethral resection, transurethral incision, and open enucleation of the prostate clearly pass this test, although holmium-laser enucleation probably also qualifies but is not discussed. It would be useful to see a management algorithm that ranked these therapies into some sort of hierarchy of effectiveness. One suspects that fashion, remuneration, and the individual views of patients and urologists determine choice. In summary, the book provides a lot of useful information that will guide the clinicians who care for patients with lower urinary tract symptoms. The literature on the multifarious forms of treatment for prostatic obstruction is reviewed well. The editors appear not to have encouraged categorical recommendations, an attitude that will be welcomed by many but regretted by some. Paul Abrams, M.D.
Copyright © 2005 Massachusetts Medical Society. All rights reserved. The New England Journal of Medicine is a registered trademark of the MMS.

Review

"This is a high quality, comprehensive review of BPH management. The book covers the major aspects of managing a patient with BPH including a thorough discussion of pathophysiology, diagnostic evaluation, and medical/surgical/procedural intervention. The evaluation and pathophysiology chapters are handled quite well as are the minimally invasive therapies. This type of review, particularly if followed by updated editions, would greatly assist practicing urologists in providing a practical review of the topic and in staying on the cutting edge in treating patients with BPH. "-Doody's Health Sciences Book Review Journal

Product Details


Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Inside This Book (learn more)
First Sentence:
The prostate is the major accessory sex gland of the male. Read the first page
Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
simple perineal prostatectomy, bridge catheter, patients taking finasteride, mean prostate volume, energy transurethral microwave thermotherapy, unobstructed patients, surgical capsule, detrusor hypocontractility, transurethral vaporization, finasteride group, finasteride therapy, prostatic fossa, catheter traction, transurethral needle ablation, transurethral electrovaporization, glandular prostate, bladder closure, catheterization time, maximum urinary flow rate, benign prostatic obstruction, peak urinary flow rates, transurethral incision, open prostatectomy, interstitial laser coagulation, bladder neck incision
Key Phrases - Capitalized Phrases (CAPs): (learn more)
Eur Urol, United States, Urol Nephrol, Humana Press Inc, Management of Benign Prostatic Hypertrophy Edited, American Urological Association, Neurourol Urodyn, Grayhack Fig, New York, Urol Clin, Campbell's Urology, Department of Health, Public Health Service, Curr Opin Urol, Atlas of Urologic Surgery, Clin Endocrinol Metab, Clin Epidemiol, Dominican Republic, Isis Medical Media Ltd, Tech Urol, Urol Int, Writing Committee
New!
Books on Related Topics | Concordance | Text Stats
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Search Inside This Book:




Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Sell a Digital Version of This Book in the Kindle Store

If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store. Learn more

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject